SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-06-009891
Filing Date
2006-05-15
Accepted
2006-05-15 08:01:58
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2006 a20563e10vq.htm 10-Q 526716
2 EXHIBIT 10.267 a20563exv10w267.htm EX-10.267 125544
3 EXHIBIT 31.1 a20563exv31w1.htm EX-31.1 6341
4 EXHIBIT 31.2 a20563exv31w2.htm EX-31.2 6333
5 EXHIBIT 32.1 a20563exv32w1.htm EX-32.1 3586
6 EXHIBIT 32.2 a20563exv32w2.htm EX-32.2 3579
  Complete submission text file 0000950134-06-009891.txt   673510
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 06836972
SIC: 2834 Pharmaceutical Preparations